Tuesday, January 16, 2024 4:41:30 PM
Recent CRSP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 09:37:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 09:37:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 09:35:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:06:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:35:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/12/2026 09:35:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 11:07:39 AM
- CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering • GlobeNewswire Inc. • 03/11/2026 11:00:00 AM
- CRISPR Therapeutics shares drop after announcing convertible notes sale • IH Market News • 03/10/2026 12:46:28 PM
- CRISPR Therapeutics Announces Proposed Convertible Senior Notes Offering • GlobeNewswire Inc. • 03/10/2026 11:00:00 AM
- Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 • PR Newswire (US) • 02/25/2026 02:00:00 PM
- Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 • PR Newswire (Canada) • 02/25/2026 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 10:36:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2026 10:35:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2026 09:35:28 PM
- CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/12/2026 09:30:00 PM
- Cutting DNA, Cutting Edge: Companies Using CRISPR and Other Gene Editing Technologies to Rewrite the Future of Industry and Medicine • GlobeNewswire Inc. • 01/28/2026 01:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/27/2026 10:35:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 10:35:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/22/2026 10:55:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2026 10:15:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2026 09:03:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/20/2026 10:11:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:44:04 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
